Avidity Biosciences
RNA
#2595
Rank
HK$43.33 B
Marketcap
HK$363.18
Share price
-1.66%
Change (1 day)
748.66%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : HK$10.09 Billion

According to Avidity Biosciences's latest financial reports the company has HK$10.09 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$4.64 B-2.56%
2022-12-31HK$4.77 B50.9%
2021-12-31HK$3.16 B24.31%
2020-12-31HK$2.54 B245.35%
2019-12-31HK$0.73 B2944.05%
2018-12-31HK$24.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$7.87 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$72.79 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.31 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.43 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.36 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$77.36 B 666.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$33.41 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK